Breaking News

Adaptive Biotechnologies Triples Footprint

Signs lease for new 100,000 sq. ft. corporate HQ in Seattle’s growing biotech hub

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Adaptive Biotechnologies has unveiled plans to lease a new corporate headquarters with a state-of-the-art office space and research facility that will triple the company’s Seattle footprint.  Adaptive has signed a 12-year, full-building, 100,000 square foot lease with long-time partner Alexandria Real Estate Equities, Inc. at 1165 Eastlake Avenue East, in the heart of Seattle’s Lake Union life science cluster.   “We have worked with Alexandria to design a state-of-the-art headquarters that will ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters